Suplemento dietético AHCC patentado japonés (de hongos shiitake)

Cada cápsula contiene 500 mg de extracto de raíz de hongo shiitake (Lentinus edodes).

Adultos. Tomar dos cápsulas al día. Cada cápsula contiene 500 mg de AHCC® (extracto de micelio de Shiitake (Lentinus edodes) estandarizado a un 10% de alfa glucanos).

Precauciones: no sobrepasar la dosis diaria recomendada. Este producto es un complemento nutricional que no debe sustituir a una alimentación variada y equilibrada, ni a un modo de vida sano. No dejar al alcance de los niños pequeños. Conservar alejado de la luz, del calor y de la humedad. Como con todo complemento nutricional, consulte a un profesional de la salud antes de consumirlo si usted está embarazada, en periodo de lactancia, o si tiene un problema de salud.

1. Meng X, Liang H, Luo L. Antitumor polysaccharides from mushrooms: a review on the structural characteristics, antitumor mechanisms and immunomodulating activities. Carbohydr Res 2016;424:30–41.
2. Sato K, Kashimoto M. Profile summary of AHCC: composition. In Clinician’s Guide to AHCC. Kulkarni AD, Calder PC. Ito T. Eds.: 24–33; International Congress on Nutrition and Integrative Medicine; 2017
3. Roman BE, Beli E, Duriancik DM, Gardner EM. Shortterm supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine. Nutr Res 2013;33:12–7.
4. Nogusa S, Gerbino J, Ritz BW. Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice. Nutr Res 2009;29:139–43
5. Ritz BW, Nogusa S, Ackerman EA, Gardner EM. Supplementation with active hexose correlated compound increases the innate immune response of young mice to primary influenza infection. J Nutr 2006;136:2868–73.
6. Thaiudom S, Piyaniran W, Chutaputthi A. A study of the efficacy of active hexose correlated compound (AHCC) in the treatment of chronic hepatitis C patients at Phramongkutklao Hospital. Med News Thailand 2010;325:13–6
7. Smith JA, Mathew L, Gaikwad A, Rech B, Burney MN, Faro JP, et al. From Bench to Bedside: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus Infections. Front Oncol 2019;9:173
8. Lee N., Shin M. S., Kang I. T-cell biology in aging, with a focus on lung disease. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2012;67A(3):254–263. doi: 10.1093/gerona/glr237
9. Schultz-Cherry S. Role of NK cells in influenza infection. Current Topics in Microbiology and Immunology. 2015;386:109–120. doi: 10.1007/82_2014_403.
10. Morvan M. G., Lanier L. L. NK cells and cancer: you can teach innate cells new tricks. Nature Reviews. Cancer. 2016;16(1):7–19. doi: 10.1038/nrc.2015.5.
11. Sharma P., Allison J. P. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell. 2015;161(2):205–214. doi: 10.1016/j.cell.2015.03.030.